Closing arguments for the FDA LDT federal court case were submitted in December 2025.
As reported by Christine Bump at Linked In, now oral arguments have been scheduled for February 19, 2025.
To my eye, that pushes a judge's decision to at least late March if not April.
ACLA/AMP requested an oral hearing, which wasn't required. This may give them a chance to emphasize those arguments most in tune with the judge's questions, or to clear up any misunderstanding that a judge's question might reveal. Also, it might let ACLA/AMP get a temperature check on the tone of the justice department in light of the new administration (and, by February 19, possibly a new head of HHS and of FDA).
https://www.linkedin.com/posts/christinepbump_ldts-activity-7288552664173318144-cUMd/
##
Find Christine at Penn Avenue Law.